Decentralized Clinical Trials: Big Pharma’s New Frontier
In a recent webinar, industry luminaries including Harpreet Gill from ICON plc, Jane Twitchen from Biogen, Angela May from...
Moe Alsumidaie
CRO Performance: A Forgotten Voice of The Site’s Perspective
Contract Research Organizations (CROs) and vendors stand as pillars in clinical trials, with sponsors thoroughly building Key Performance Indicators...
How to Use Real World Data in Clinical Trials
Integrating real world data into clinical trials is an emerging frontier, offering a transformative approach to clinical trial designs,...
DCT Recruitment: The Future is Now, and It’s Digital
In a recent panel discussion, leading experts from the clinical trials industry, including Craig Lipset with the Decentralized Trials...
Psychedelic Therapy: A New Frontier for Mental Health
Psychedelic therapy is a rapidly growing field with the potential to revolutionize the treatment of mental health disorders. In...
The Rise of The “Metasite” in Decentralized Clinical Trials
Decentralized clinical trials are at a pivotal juncture, shaped by technological advancements and evolving regulatory landscapes. While traditional clinical...
Decentralized Clinical Trials: How the FDA is Supporting its Growth
As the clinical trials industry embraces change, Decentralized Clinical Trials (DCTs) are emerging as the next significant evolution. Marrying...
Navigating Compassionate Use in Clinical Research: Unpacking FDA’s Latest Guidance
Compassionate use, also known as expanded access, is a critical pathway for patients with life-threatening conditions to access investigational...
How to Harness Data Science to Predict Clinical Trial Outcomes
In today’s world, where data drives many decisions, the biopharmaceutical industry is no exception. Integrating data science into clinical...
Are Clinical Research Sites Just Whiners or Genuine Victims?
In recent times, LinkedIn has transformed from a platform for professional networking to a sounding board for industry grievances....